167 related articles for article (PubMed ID: 10602520)
21. Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation: a pathologic, cytogenetic, and molecular study of a case with a novel translocation t(9;17)(q22;q11.2).
Harris M; Coyne J; Tariq M; Eyden BP; Atkinson M; Freemont AJ; Varley J; Attwooll C; Telford N
Am J Surg Pathol; 2000 Jul; 24(7):1020-6. PubMed ID: 10895826
[TBL] [Abstract][Full Text] [Related]
22. Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study.
Antonescu CR; Argani P; Erlandson RA; Healey JH; Ladanyi M; Huvos AG
Cancer; 1998 Oct; 83(8):1504-21. PubMed ID: 9781944
[TBL] [Abstract][Full Text] [Related]
23. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma.
Rabbitts TH; Forster A; Larson R; Nathan P
Nat Genet; 1993 Jun; 4(2):175-80. PubMed ID: 7503811
[TBL] [Abstract][Full Text] [Related]
24. Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes.
Morohoshi F; Ootsuka Y; Arai K; Ichikawa H; Mitani S; Munakata N; Ohki M
Gene; 1998 Oct; 221(2):191-8. PubMed ID: 9795213
[TBL] [Abstract][Full Text] [Related]
25. The oncogenic fusion protein EWS/NOR-1 induces transformation of CFK2 chondrogenic cells.
Filion C; Labelle Y
Exp Cell Res; 2004 Jul; 297(2):585-92. PubMed ID: 15212958
[TBL] [Abstract][Full Text] [Related]
26. t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases.
Sciot R; Dal Cin P; Fletcher C; Samson I; Smith M; De Vos R; Van Damme B; Van den Berghe H
Mod Pathol; 1995 Sep; 8(7):765-8. PubMed ID: 8539235
[TBL] [Abstract][Full Text] [Related]
27. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
[TBL] [Abstract][Full Text] [Related]
28. Localization of TEC to 9q22.3-q31 by fluorescence in situ hybridization.
Kleinfinger P; Labelle Y; Melot T; Thomas G; Delattre O; Aurias A
Ann Genet; 1996; 39(4):233-5. PubMed ID: 9037350
[TBL] [Abstract][Full Text] [Related]
29. Spectrum of cytomorphological features, including literature review, of an extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q12) (TEC/EWS) results in one case.
Kumar R; Rekhi B; Shirazi N; Pais A; Amare P; Gawde D; Jambhekar N
Diagn Cytopathol; 2008 Dec; 36(12):868-75. PubMed ID: 18925568
[TBL] [Abstract][Full Text] [Related]
30. Translocation t(9;22)(q22;q12) is a primary cytogenetic abnormality in extraskeletal myxoid chondrosarcoma.
Stenman G; Andersson H; Mandahl N; Meis-Kindblom JM; Kindblom LG
Int J Cancer; 1995 Aug; 62(4):398-402. PubMed ID: 7635565
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation.
Kanoe H; Nakayama T; Hosaka T; Murakami H; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Ron D; Sasaki MS; Toguchida J
Oncogene; 1999 Jan; 18(3):721-9. PubMed ID: 9989822
[TBL] [Abstract][Full Text] [Related]
32. Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma.
Storlazzi CT; Mertens F; Nascimento A; Isaksson M; Wejde J; Brosjo O; Mandahl N; Panagopoulos I
Hum Mol Genet; 2003 Sep; 12(18):2349-58. PubMed ID: 12915480
[TBL] [Abstract][Full Text] [Related]
33. Skeletal and extraskeletal myxoid chondrosarcoma: related or distinct tumors?
Rubin BP; Fletcher JA
Adv Anat Pathol; 1999 Jul; 6(4):204-12. PubMed ID: 10410173
[TBL] [Abstract][Full Text] [Related]
34. Extraskeletal myxoid chondrosarcoma arising in the finger.
Okamoto S; Hara K; Sumita S; Sato K; Hisaoka M; Aoki T; Hashimoto H
Skeletal Radiol; 2002 May; 31(5):296-300. PubMed ID: 11981607
[TBL] [Abstract][Full Text] [Related]
35. The AF2 domain of the orphan nuclear receptor TEC is essential for the transcriptional activity of the oncogenic fusion protein EWS/TEC.
Maltais A; Filion C; Labelle Y
Cancer Lett; 2002 Sep; 183(1):87-94. PubMed ID: 12049818
[TBL] [Abstract][Full Text] [Related]
36. The TFG-TEC oncoprotein induces transcriptional activation of the human β-enolase gene via chromatin modification of the promoter region.
Kim AY; Lim B; Choi J; Kim J
Mol Carcinog; 2016 Oct; 55(10):1411-23. PubMed ID: 26310886
[TBL] [Abstract][Full Text] [Related]
37. The PLAGL1 gene is down-regulated in human extraskeletal myxoid chondrosarcoma tumors.
Poulin H; Labelle Y
Cancer Lett; 2005 Sep; 227(2):185-91. PubMed ID: 16112421
[TBL] [Abstract][Full Text] [Related]
38. The hTAF II 68-TEC fusion protein functions as a strong transcriptional activator.
Kim S; Lee HJ; Jun HJ; Kim J
Int J Cancer; 2008 Jun; 122(11):2446-53. PubMed ID: 18330902
[TBL] [Abstract][Full Text] [Related]
39. Extraskeletal myxoid chondrosarcoma: multimodal diagnosis and identification of a new cytogenetic subgroup characterized by t(9;17)(q22;q11).
Bjerkehagen B; Dietrich C; Reed W; Micci F; Saeter G; Berner A; Nesland JM; Heim S
Virchows Arch; 1999 Nov; 435(5):524-30. PubMed ID: 10592057
[TBL] [Abstract][Full Text] [Related]
40. Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features.
Dal Cin P; Sciot R; Panagopoulos I; Aman P; Samson I; Mandahl N; Mitelman F; Van den Berghe H; Fletcher CD
J Pathol; 1997 Aug; 182(4):437-41. PubMed ID: 9306965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]